Abstract:In this paper; the novel compounds {[(n-Bu)(2)Sn(4-Fc-C6H4COO)](2)O}(2) (1) and {[(n-Oct)(2)Sn(4-Fc-C6H4COO)](2)O}(2) (2) (Fc = ferrocenyl) have been synthesized and characterized by elemental analysis, IR and NMR (H-1, C-13 and Sn-119) spectroscopy. The crystal structure of compound 1 has been determined by single crystal X-ray diffraction techniques. The crystal belongs to monoclinic with space group P2(1)/c. The cell parameters are: a = 1.298 8(1) nm, b = 2.465 5(1) nm, c = 3. 450 6 (1) nm, beta = 91.556(2)degrees, V = 11. 045 4(1) nm(3), Z = 4. The structure was refined to final R-f = 0.071, R-w = 0.074. Compound 1 is a dimer structure mode with a four-member central endo-cyclic Sn2O2 unit in which the bridged oxygen atoms are tri-coordinated. Each bridged oxygen atom also connects an exo-cyclic tin atom. Both endo- and exo-cyclic tin atoms are all five-coordination and have coordination geometry of monocapped trigonal bipyramid with very similarly distorted mode. Four carboxylate ligands are divided into two types. Two of the carboxylate ligands are bidentate and bridging to each pair of exo- and endocyclic tin atoms by using both oxygen atoms. The others are monodentate and coordinate each exo-cyclic tin atom. When considering further the longer distance interactions between the carboxyl oxygen in carboxylate ligand and endo-cyclic tin atom (0. 277 5-0. 286 6 nm) and between the ester oxygen in carboxylate ligand and exo-cyclic tin atom (0. 298 0-0. 300 6 nm), not only carboxylate ligand chelates to exo-cyclic tin by anisobidentate mode but also their ester oxygen itself is tricoordinated and bridges to both endo- and exo-cyclic tin atoms. In compound 1, the coplanarity of two conjugate systems (benzoyloxy group and substituted Cp ring) is not good. And two conjugate systems can not be coplanar with the central endo-cyclic Sn2O2 unit. Unlike the general compounds characteristic of {[R2Sn(O2CR')](2)O}(2), there is no center of symmetry in the molecule structure of compound 1.

Synthesis and crystal structure of complex (n-Bu)2Sn(C 10H8N2O4)(C2H 5OH)

Synthesis And Crystal Structure Of Complex (N-Bu)(2)Sn(C10h8n2o4)(C2h5oh)

Synthesis and Crystal Structure of Di-N-Butyltin(Iv) Complex with 2-Oxo-propionic Acid (4-Pyridinecarbonyl) Hydrazone

Synthesis, spectroscopic characterization and crystal structure of complex {(n-Bu)2Sn[(η5-C5H5)Fe(η 5-C5H4)COO]2}2

Synthesis and Crystal Structure of an Mn(II) Complex with Benzoylacetone

Synthesis and Characterization of Binuclear Complexes Containing Alkoxo and Carboxylato Bridges

Salicylaldehyde 4-Nitrophenylhydrazone

Synthesis and crystal structure of bis[N-(3-hydroxypropyl)-3-methoxyl-salicyldimino]-isothiocyanato-manganese (III)

Synthesis And Structure Of (Oxydiacetato)-Nickel(Ii) Complex With Diaminobithiazole

Synthesis, Spectroscopic Characterization And Crystal Structure Of Complex {(N-Bu)(2)Sn[(Eta(5)-C5h5)Fe(Eta(5)-C5h4)Coo](2)}(2)

Synthesis, crystal structure and thermal decomposition of copper(II) complex with imidazole and 2 oxo-propionic acid salicyloyl hydrazone

Catena-Poly[[bis(1h-benzimidazole-κn3)(salicylato-κo)copper(ii)]-μ-salicylato-o,o′:O′′]

Synthesis, Spectroscopic Characterization of Bis-[oxo-bis(4-ferrocenylbenzoato dialkyltin(IV))] and Crystal Structural Studies of the Former Compound

Crystal Structure and Biological Activity of Copper (ii) Complex with Two Aqua and 2-Oxo-propionic Acid Salicyloyl Hydrazone

Synthesis and Crystal Structure of New Salicylate-Bridged Coordination Polymer, [Cu2(sal)2(pyz)(meoh)2]n

Synthesis and characterization of Zinc(II) complex with (1R, 2R)-(-)-Diaminocyclohexane-N,N'-bis(3-tert-butyl-5 -(4'-methylbenzoate)- salicylidene)

Synthesis, molecular, and crystal structure of a new organotin/Schiff-base complex C28H31Cl3NO4Sn

A tetranuclear organotin compound consisting of a core of three fused Sn2O2 rings.

Catena-Poly[[hexakis(1h-benzimidazole)bis(μ2-5-sulfonatosalicylato)tricopper(ii)] Octahydrate]

Catena-Poly[[Hexakis(1h-Benzimidazole)-Bis(Mu(2)-5-Sulfonatosalicylato)T Ricopper(Ii)]Octahydrate]

Bis(benzimidazole-κN)bis(salicylato-κ2O,O′)cadmium(II) Monohydrate